Will There Be a Cure for COVID?

Cytodyn Inc (OTCMKTS:CYDY), a late-stage biotech drug developer, has already delivered a win for Wealthpress subscribers from our first feature back in April this year. Billions have been invested into hundreds of biotechs all competing to produce a cure or treatment for severe COVID-19 instances that cause death, and none have succeeded. Except Cytodyn, if early indications are confirmed in the current trial now underway.

Where's the Next Big Bull Market? February 2, 2021 Over the last week, we have seen major moves in GameStop, Blackberry, Silver… But, the steam seems to be finally running out. GME is down more than 200% since its highs... So what's the next big move? I see it being a disruption to technology as we know it… A new tech is scheduled to replace 5G before it really even gets off the ground... Early investors of this technology could reap all of the rewards! Join me here and I'll explain James West, CEO Midas Letter. James West is a professional trader and a successful entrepreneur with over 10 years of experience in the financial markets. Will There Be a Cure for COVID? Cytodyn Inc (OTCMKTS:CYDY), a late-stage biotech drug developer, has already delivered a win for Wealthpress subscribers from our first feature back in April this year.  Billions have been invested into hundreds of biotechs all competing to produce a cure or treatment for severe COVID-19 instances that cause death, and none have succeeded. Except Cytodyn, if early indications are confirmed in the current trial now underway. If the company's drug does in fact reliably save lives in severe-to-critical COVID19 patients, then a groundswell of investor support could push the company into new, higher-grade relationships, which would allow for the redemption of debentures and elimination of reliance on fly-by-night financings such as those described in the FULL ARTICLE. I expect the data from the trial now concluded for just such an indication could launch the company into a whole new valuation altitude. Average trading volume is steady above 6 million shares a day, and before the end of this week, we'll know just how effective their treatments are at saving lives from the worst of COVID 19. If the results are positive, this could be a big winner. Read all my thoughts HERE on the company and their latest developments to see if they are worth a buy/hold. Learn more Learn more Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein. Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment. Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.

Sent to: indra21poetra@gmail.com

Unsubscribe

WealthPress, 1749 NE Miami Ct, #507, Miami, FL 33132, United States